Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
Open Access
- 15 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 15 (1), R3
- https://doi.org/10.1186/bcr3374
Abstract
Elafin is an elastase-specific inhibitor with increased transcription in normal mammary epithelial cells compared to mammary carcinoma cells. In this report, we test the hypothesis that inhibition of elastase, through induction of elafin, leads to inhibition of human breast cancer cell viability and, therefore, predicts survival in breast cancer patients. Panels of normal and immortalized breast epithelial cells, along with breast carcinoma cells, were used to examine the impact of adenoviral-mediated elafin expression or shRNA-mediated inhibition of elastase on the growth of cells and xenografts in nude mice. To determine the prognostic significance of decreased elafin in patients with invasive breast cancer, previously published gene array datasets were interrogated. Elafin expression had no effect on non-tumorigenic cells but resulted in marked inhibition of cell growth in breast cancer cell lines. Control-treated xenografts generated a tumor burden that necessitated sacrifice within one month of initial treatment, whereas xenograft-bearing mice treated with Ad-Elafin were alive at eight months with marked reduction in tumor growth. Elastase inhibition mimicked these results, showing decreased tumor cell growth in vitro and in vivo. Low expression of elafin gene correlated with significantly reduced time to relapse, and when combined with high expression of elastase gene was associated with decreased survival in breast cancer patients. Our data suggest that elafin plays a direct role in the suppression of tumors through inhibition of elastase and thus serves as a prognostic indicator for breast cancer patients.Keywords
This publication has 37 references indexed in Scilit:
- Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune ResponseCancer Research, 2012
- Modifying the Protease, Antiprotease Pattern by Elafin Overexpression Protects Mice From ColitisGastroenterology, 2011
- The Neutrophil Elastase Inhibitor Elafin Triggers Rb-Mediated Growth Arrest and Caspase-Dependent Apoptosis in Breast CancerCancer Research, 2010
- Proteolytic Processing of Cut Homeobox 1 by Neutrophil Elastase in the MV4;11 Myeloid Leukemia Cell LineMolecular Cancer Research, 2008
- Neutrophil elastase and cancerSurgical Oncology, 2006
- CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasivenessCancer Cell, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- Gene delivery of the elastase inhibitor elafin protects macrophages from neutrophil elastase-mediated impairment of apoptotic cell recognitionFEBS Letters, 2004
- The Low Molecular Weight Isoforms of Cyclin E Deregulate the Cell Cycle of Mammary Epithelial CellsCell Cycle, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002